Zobrazeno 1 - 10
of 56
pro vyhledávání: '"C W, Howden"'
Autor:
C. W. Howden
Publikováno v:
Alimentary Pharmacology & Therapeutics Symposium Series. 3:39-45
Summary Once daily, or even twice daily, dosing with proton-pump inhibitors does not reliably achieve optimal control of nocturnal intragastric acidity. The phenomenon of nocturnal acid breakthrough, defined as intragastric pH 4 for the duration of t
Autor:
V K, Sharma, S, Komanduri, S, Nayyar, A, Headly, P, Modlinger, D C, Metz, V J, Verghese, A, Wanahita, M F, Go, C W, Howden
Publikováno v:
American Journal of Gastroenterology. 96:1256-1260
Recent surveys of physician practice have suggested the existence of excessive, inappropriate use of the fecal occult blood test (FOBT). We studied the implementation of this test in hospitalized patients.We performed a retrospective chart review of
Publikováno v:
American Journal of Gastroenterology. 93:702-705
Esophageal adenocarcinoma is increasing in white men. We sought to identify trends in esophageal cancer in different patient groups in our region.We reviewed the records of all patients with esophageal cancer seen at two hospitals in Columbia, SC bet
Autor:
C. W. Howden
Publikováno v:
Archives of Internal Medicine. 155:1465-1471
Autor:
G I, Leontiadis, C W, Howden
Publikováno v:
Alimentary pharmacologytherapeutics. 35(2)
Publikováno v:
Alimentary pharmacologytherapeutics. 25(6)
In July 2001, our Veterans' Affairs hospital changed its formulary proton pump inhibitor (PPI) from lansoprazole to rabeprazole. All patients previously receiving lansoprazole 30 mg twice daily were switched to rabeprazole 20 mg once daily.To determi
Publikováno v:
The Cochrane database of systematic reviews. (1)
Randomised controlled trials (RCTs) evaluating the clinical effect of proton pump inhibitors (PPIs) in peptic ulcer (PU) bleeding yield conflicting results.To evaluate the efficacy of PPIs in acute bleeding from PU using evidence from RCTs.We searche
Autor:
C. W. Howden
Publikováno v:
Archives of Internal Medicine. 157:1771-1773
Publikováno v:
Alimentary pharmacologytherapeutics. 20(11-12)
Proton-pump inhibitors are often recommended for continuous use in gastro-oesophageal reflux disease, but this may not be necessary in all patients.To ascertain the level of evidence for alternative strategies for proton-pump inhibitor treatment in g
Autor:
J, Pisegna, G, Holtmann, C W, Howden, P H, Katelaris, P, Sharma, S, Spechler, G, Triadafilopoulos, G, Tytgat
Publikováno v:
Alimentary pharmacologytherapeutics. 20
The major oesophageal complications associated with persistent gastro-oesophageal reflux disease (GERD) include erosive oesophagitis, ulceration, strictures and gastrointestinal (GI) bleeding. Although the causes of these complications are uncertain,